The gamma protein fraction by SPEP was higher in AID-Cre-YFP KrasG12DArf −/− at 12 weeks compared to AID-Cre-YFP Arf −/− controls (Figure S4C), but none of the mice developed multiple myeloma or monoclonal gammopathy. The gene discussed is CDKN2A; the disease is plasma cell myeloma.